The Ups and Downs of Endocannabinoid Signaling in Chronic Pain-Induced Depression
Explore this paper's citation graph
- Type
- letter
- Published
- 2022-03-16
- Cited by
- 2
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W4220705158
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:247475466
Keywords
Depression (economics), Chronic pain, Endocannabinoid system, Neuropathic pain, Medicine
References
No references recorded for this paper.
Cited by
Related papers
- Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
- Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
- Frequency of chronic neuropathic pain and its association with depression in the elderly in Pakistan.
- Frequency of chronic neuropathic pain and its association with depression in elderly in Pakistan
- Psychiatry Chronic low‐back pain and depression: an epidemiological survey
- The psychopharmacologic treatment of depression and anxiety in the context of chronic pain
- Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
- O-13: INHIBITION OF THE ENDOCANNABINOID REGULATING ENZYME MONOACYLGLYCEROL LIPASE AMELIORATES THE HYPER-NOCICEPTIVE PHENOTYPE IN THE BERKELEY MOUSE MODEL OF SICKLE CELL DISEASE